Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,550
Views
19
CrossRef citations to date
0
Altmetric
Coronaviruses

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Shixia Wanga Vaxxinity, Inc., Dallas, TX, USA
,
Chang Yi Wangb United Biomedical Inc., Asia, Taipei, Taiwan;c United BioPharma, HuKo, Taiwan
,
Hui-Kai Kuob United Biomedical Inc., Asia, Taipei, Taiwan
,
Wen-Jiun Pengb United Biomedical Inc., Asia, Taipei, Taiwan
,
Juin-Hua Huangb United Biomedical Inc., Asia, Taipei, Taiwan
,
Be-Shen Kuoc United BioPharma, HuKo, Taiwan
,
Feng Lind United Biomedical Inc., Hauppauge, NY, USA
,
Yaw-Jen Liuc United BioPharma, HuKo, Taiwan
,
Zhi Liud United Biomedical Inc., Hauppauge, NY, USA
,
Huang-Ting Wub United Biomedical Inc., Asia, Taipei, Taiwan
,
Shuang Dingd United Biomedical Inc., Hauppauge, NY, USA
,
Kou-Liang Houb United Biomedical Inc., Asia, Taipei, Taiwan
,
Jennifer Chengb United Biomedical Inc., Asia, Taipei, Taiwan
,
Ya-Ting Yangb United Biomedical Inc., Asia, Taipei, Taiwan
,
Ming-Han Jiangb United Biomedical Inc., Asia, Taipei, Taiwan
,
Min-Sheng Wangb United Biomedical Inc., Asia, Taipei, Taiwan
,
Tony Chenb United Biomedical Inc., Asia, Taipei, Taiwan
,
Wei Guo Xiad United Biomedical Inc., Hauppauge, NY, USA
,
Ed Lind United Biomedical Inc., Hauppauge, NY, USA
,
Chung Ho Hungd United Biomedical Inc., Hauppauge, NY, USA
,
Hui-Jung Chenc United BioPharma, HuKo, Taiwan
,
Zhonghao Shihc United BioPharma, HuKo, Taiwan
,
Yi Ling Line Emerging Infectious Disease Division, Academia Sinica, Nangang, Taiwan
,
Valorie Ryana Vaxxinity, Inc., Dallas, TX, USA
,
Mei Mei Hua Vaxxinity, Inc., Dallas, TX, USA;d United Biomedical Inc., Hauppauge, NY, USA
,
D. Gray Heppnera Vaxxinity, Inc., Dallas, TX, USA
,
Delphine C. Malherbef Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;h Galveston National Laboratory, Galveston, TX, USA
,
Sivakumar Periasamyf Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;h Galveston National Laboratory, Galveston, TX, USA
,
Natalia Kuzminaf Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;h Galveston National Laboratory, Galveston, TX, USA
,
Chandru Subramanif Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;h Galveston National Laboratory, Galveston, TX, USA
,
Michael Hellersteina Vaxxinity, Inc., Dallas, TX, USA
,
Thomas P. Monatha Vaxxinity, Inc., Dallas, TX, USA
,
Alexander Rumyantseva Vaxxinity, Inc., Dallas, TX, USA
,
Alexander Bukreyevf Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;g Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA;h Galveston National Laboratory, Galveston, TX, USA
&
Farshad Guirakhooa Vaxxinity, Inc., Dallas, TX, USACorrespondence[email protected]
 show all
Pages 2724-2734 | Received 27 Jul 2022, Accepted 21 Oct 2022, Published online: 11 Nov 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.